| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/02/2013 | US20130108619 Intravenous immunoglobulin processing, diagnostic, and treatment systems and methods |
| 05/02/2013 | US20130108618 METHODS AND COMPOSITIONS RELATED TO INTRACELLULAR NEUTRALIZATION BY IgG |
| 05/02/2013 | US20130108617 Plasma-derived immunoglobulin for use in the treatment and prevention of immune reconstitution inflammatory syndrome (iris) |
| 05/02/2013 | US20130108580 Fusion protein and its uses |
| 05/02/2013 | US20130108547 Recombinantly Produced Antibodies Targeting ErbB Signaling Molecules and Methods of Use Thereof for the Diagnosis and Treatment of Disease |
| 05/02/2013 | US20130108546 Humanized Antibodies That Recognize Alpha-Synuclein |
| 05/02/2013 | CA2853823A1 Protein formulations containing amino acids |
| 05/02/2013 | CA2853734A1 Methods and compositions related to intracellular neutralization by igg |
| 05/02/2013 | CA2853719A1 Humanized antibodies to inkt |
| 05/02/2013 | CA2853705A1 Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer |
| 05/02/2013 | CA2853637A1 Monoclonal antibodies and methods of use |
| 05/02/2013 | CA2853531A1 Humanized antibodies that recognize alpha-synuclein |
| 05/02/2013 | CA2853258A1 Immunobinders directed against sclerostin |
| 05/02/2013 | CA2853247A1 Il-19 as a biomarker of tslp treatment |
| 05/02/2013 | CA2853187A1 A method of treating mucus hypersecretion |
| 05/02/2013 | CA2853114A1 Bispecific immunobinders directed against tnf and il-17 |
| 05/02/2013 | CA2853112A1 Antibody formulations and methods |
| 05/02/2013 | CA2851545A1 Cd44 monoclonal antibody for the treatment of b-cell chronic lymphocytic leukemia and other hematological malignancies |
| 05/02/2013 | CA2851336A1 Improved hcv vaccines and methods for using the same |
| 05/02/2013 | CA2850034A1 Therapeutic combinations and methods of treating melanoma |
| 05/01/2013 | EP2586798A2 B-cell reduction using CD37-specific and CD20-specific binding molecules |
| 05/01/2013 | EP2586796A1 Compositions and methods for use for antibodies against sclerostin |
| 05/01/2013 | EP2586795A2 Use of anti-amyloid beta antibody in ocular diseases |
| 05/01/2013 | EP2586790A2 Immunogens from uropathogenic Escherichia coli |
| 05/01/2013 | EP2586461A1 Viral particles derived from an enveloped virus |
| 05/01/2013 | EP2586460A1 Method for designing and preparing vaccines comprising directed sequence polymer composition via the directed expansion of epitopes |
| 05/01/2013 | EP2586447A1 Heterochain aliphatic poly-n-oxide copolymers and vaccinating agents and drugs based thereon |
| 05/01/2013 | EP2585828A2 Methods of treating patients with immune-related diseases |
| 05/01/2013 | EP2585607A2 Dual variable domain immunoglobulins and uses thereof |
| 05/01/2013 | EP2585598A2 Pan-lyssavirus vaccines against rabies |
| 05/01/2013 | EP2585584A1 Means of controlling infection persistence of helicobacter pylori |
| 05/01/2013 | EP2585110A1 Antibodies to the c3d fragment of complement component 3 |
| 05/01/2013 | EP2585109A2 Compositions and methods for preventing and treating organ injury and/or dysfunction |
| 05/01/2013 | EP2585108A1 Conjugates comprising an n-oxime bond and associated methods |
| 05/01/2013 | EP2585107A1 Homodimeric protein constructs |
| 05/01/2013 | EP2585106A1 Combinations of meningococcal factor h binding proteins |
| 05/01/2013 | EP2585053A2 Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones |
| 05/01/2013 | CN103080136A Anti-Axl antibodies and methods of use |
| 05/01/2013 | CN103080135A Antibodies that are capable of specifically binding tissue factor pathway inhibitor |
| 05/01/2013 | CN103080134A Antibodies for epidermal growth factor receptor 3 (HER3) |
| 05/01/2013 | CN103080132A Antibodies against IL-18R1 and uses thereof |
| 05/01/2013 | CN103080131A Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies |
| 05/01/2013 | CN103079644A Anti-TIM-3 antibody |
| 05/01/2013 | CN103079594A Uses and compositions for treatment of hidradenitis suppurativa (HS) |
| 05/01/2013 | CN103079593A Parapoxvirus vectors |
| 05/01/2013 | CN103079592A Method for treating and diagnosing cancer by using cell-derived microvesicles |
| 05/01/2013 | CN103079591A Capsular gram-positive bacteria bioconjugate vaccines |
| 05/01/2013 | CN103079590A Method for producing toxoids using alpha - dicarbonyl compounds |
| 05/01/2013 | CN103079589A Targeted multi-epitope dosage forms for induction of an immune response to antigens |
| 05/01/2013 | CN103074316A Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 05/01/2013 | CN103074305A Recombinant varicella-zoster virus |
| 05/01/2013 | CN103074293A Culture medium for preparing influenza vaccine through MDCK cells and application method thereof |
| 05/01/2013 | CN103074291A Recombinant porcine epidemic diarrhea virus (PEDV) lactococcus lactis and its construction method and use |
| 05/01/2013 | CN103074274A Duck escherichia coli and application thereof |
| 05/01/2013 | CN103073641A Anti-human Dlk-1 antibody showing anti-tumor activity in vivo |
| 05/01/2013 | CN103073640A Anti-soft-shelled turtle systemic septicemia spherical virus (STSSSV) yolk antibody, preparation method and applications thereof |
| 05/01/2013 | CN103073636A Dermtophagoides farinae allergens Der f 29 and Der f 30, and genes and applications thereof |
| 05/01/2013 | CN103073632A Potential novel cytokine LYG1 with anti-inflammatory and anti-tumor activities, and application thereof |
| 05/01/2013 | CN103073625A Hydrophobic-region-deletion HIV (Human Immunodeficiency Virus) type I Tat protein mutant sequence and applications thereof |
| 05/01/2013 | CN103073620A KDR peptides and vaccines comprising the same |
| 05/01/2013 | CN103071160A Gene vaccine for Alzheimer's disease |
| 05/01/2013 | CN103071153A Ready-to-use adjuvant of livestock vaccines, preparation and applications thereof |
| 05/01/2013 | CN103071152A Atherosclerotic vaccine |
| 05/01/2013 | CN103071151A Special diluent for swine mycoplasmal pneumonia vaccines and preparation method of special diluent |
| 05/01/2013 | CN102676455B Preparation method for dendritic cell of umbilical cord blood source and dendritic cell vaccine |
| 05/01/2013 | CN102430118B Application of H22 liver cancer cell autophagosome to preparation of liver cancer therapeutic vaccine |
| 05/01/2013 | CN102370979B Building method for autovaccine by aiming at human TNF(Tumor Necrosis Factor)-alpha molecule |
| 05/01/2013 | CN102363043B Swine C-type foot-and-mouth disease genetic engineering vaccine adjuvant, and preparation method thereof |
| 05/01/2013 | CN102327606B Brucella live vaccine and production method thereof |
| 05/01/2013 | CN102286106B Sandwich outer membrane protein display vector and escherichia coli vaccine prepared by applying same |
| 05/01/2013 | CN101979566B Sulpho-oligodeoxynucleotide with immunostimulation activities and application thereof |
| 05/01/2013 | CN101948516B Establishment and application of vaccinia virus vector-based reverse genetics system |
| 05/01/2013 | CN101897965B Hepatitis B virus dendritic cell therapeutic vaccine and preparation method thereof |
| 05/01/2013 | CN101820907B Peptide with multiple epitopes |
| 05/01/2013 | CN101671689B Recombinant expression carrier containing schistosoma japonicum gene and application thereof |
| 05/01/2013 | CN101646457B Anti-sclerostin antibodies |
| 05/01/2013 | CN101607995B Monoclonal antibody or binding activity fragment thereof of H5 subtype avian influenza virus hemagglutinin protein and application thereof |
| 05/01/2013 | CN101489584B Recombinant attenuated clostridium organisms and vaccine |
| 05/01/2013 | CN101374548B Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 05/01/2013 | CN101094688B Multimeric constructs |
| 04/30/2013 | US8431688 Synthetic peptide constructs for the diagnosis and treatment of Periodontitis associated with Porphyromonas gingivalis |
| 04/30/2013 | US8431687 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
| 04/30/2013 | US8431585 Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH)/prostatic hypertrophy |
| 04/30/2013 | US8431537 Glue composition for lung volume reduction |
| 04/30/2013 | US8431533 GLP-1 fusion peptides, their production and use |
| 04/30/2013 | US8431530 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 04/30/2013 | US8431394 Antibody or fragment thereof recognizing Avitag™ and uses thereof |
| 04/30/2013 | US8431354 Bacterial pheromones and uses therefor |
| 04/30/2013 | US8431350 Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide |
| 04/30/2013 | US8431221 Therapeutic calcium phosphate particles and methods of manufacture and use |
| 04/30/2013 | US8431160 Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions |
| 04/30/2013 | US8431139 Nucleic acids and proteins from Streptococcus groups A and B |
| 04/30/2013 | US8431138 In ovo vaccination of Campylobacter in avian species |
| 04/30/2013 | US8431137 Influenza hemagglutinin and neuraminidase variants |
| 04/30/2013 | US8431136 Immunogenic composition |
| 04/30/2013 | US8431135 Polypeptides and methods for the specific detection of antibodies in patients with a borrelia infection |
| 04/30/2013 | US8431134 Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen |
| 04/30/2013 | US8431133 Augmentation of titer for vaccination in animals |
| 04/30/2013 | US8431132 Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 04/30/2013 | US8431131 CD38 and obesity |